Lissencephaly and Advanced-Stage Congenital Cytomegalovirus Infection in a Neonate

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Jul 4

PMID 38962590

Authors

Ahmira Jade E Manalac

Erika Lytle

Liaqat Khan

Koshy George

Affiliations

Soon will be listed here.

Abstract

This case report investigates the management of a 24-week-old neonate with congenital cytomegalovirus (CMV) infection and its sequelae, including severe intrauterine growth restriction, thrombocytopenia, and brain anomalies, ultimately progressing to lissencephaly. The diagnostic challenges included delayed clinical suspicion of congenital CMV, which was not identified until after delivery through CMV DNA polymerase chain reaction, and differentiating its symptoms from other potential causes of the neonate's condition. Aggressive interventions included antibiotics, antiviral therapy with ganciclovir, and supportive measures such as intubation, CPR, respiratory support, blood transfusions, and management of coagulopathy. Despite these efforts, the patient deteriorated due to progressive hypoperfusion, hypoxemic cardiorespiratory failure, and disseminated intravascular coagulopathy. Due to the poor prognosis and extent of multiorgan damage, support was withdrawn per parental consent. This case highlights the complications encountered when managing an advanced-stage neonatal CMV infection and emphasizes the importance of a multidisciplinary and holistic approach to guide diagnosis and treatment.

References

Bristow B, OKeefe K, Shafir S, Sorvillo F . Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Negl Trop Dis. 2011; 5(4):e1140. PMC: 3082510. DOI: 10.1371/journal.pntd.0001140. View

Bernstein D, Munoz F, Callahan S, Rupp R, Wootton S, Edwards K . Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial. Vaccine. 2015; 34(3):313-9. PMC: 4701617. DOI: 10.1016/j.vaccine.2015.11.056. View

Kimberlin D, Lin C, Sanchez P, Demmler G, Dankner W, Shelton M . Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003; 143(1):16-25. DOI: 10.1016/s0022-3476(03)00192-6. View

Oliver S, Cloud G, Sanchez P, Demmler G, Dankner W, Shelton M . Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009; 46 Suppl 4:S22-6. PMC: 2805252. DOI: 10.1016/j.jcv.2009.08.012. View

Cannon M, Schmid D, Hyde T . Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010; 20(4):202-13. DOI: 10.1002/rmv.655. View

Fowler K, McCollister F, Sabo D, Shoup A, Owen K, Woodruff J . A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening. Pediatrics. 2017; 139(2). PMC: 5260148. DOI: 10.1542/peds.2016-2128. View

Turner K, Lee H, Boppana S, Carlo W, Randolph D . Incidence and impact of CMV infection in very low birth weight infants. Pediatrics. 2014; 133(3):e609-15. PMC: 3934333. DOI: 10.1542/peds.2013-2217. View

Pinninti S, Boppana S . Congenital cytomegalovirus infection diagnostics and management. Curr Opin Infect Dis. 2022; 35(5):436-441. PMC: 10494910. DOI: 10.1097/QCO.0000000000000874. View

Chiopris G, Veronese P, Cusenza F, Procaccianti M, Perrone S, Dacco V . Congenital Cytomegalovirus Infection: Update on Diagnosis and Treatment. Microorganisms. 2020; 8(10). PMC: 7599523. DOI: 10.3390/microorganisms8101516. View

10.

Manicklal S, Emery V, Lazzarotto T, Boppana S, Gupta R . The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013; 26(1):86-102. PMC: 3553672. DOI: 10.1128/CMR.00062-12. View

11.

Salome S, Corrado F, Mazzarelli L, Maruotti G, Capasso L, Blazquez-Gamero D . Congenital cytomegalovirus infection: the state of the art and future perspectives. Front Pediatr. 2023; 11:1276912. PMC: 10687293. DOI: 10.3389/fped.2023.1276912. View

12.

Kimberlin D, Jester P, Sanchez P, Ahmed A, Arav-Boger R, Michaels M . Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015; 372(10):933-43. PMC: 4401811. DOI: 10.1056/NEJMoa1404599. View

13.

Chiereghin A, Pavia C, Turello G, Borgatti E, Baiesi Pillastrini F, Gabrielli L . Universal Newborn Screening for Congenital Cytomegalovirus Infection - From Infant to Maternal Infection: A Prospective Multicenter Study. Front Pediatr. 2022; 10:909646. PMC: 9298552. DOI: 10.3389/fped.2022.909646. View

14.

Rawlinson W, Boppana S, Fowler K, Kimberlin D, Lazzarotto T, Alain S . Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017; 17(6):e177-e188. DOI: 10.1016/S1473-3099(17)30143-3. View

15.

Lanzieri T, Dollard S, Bialek S, Grosse S . Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014; 22:44-8. PMC: 4829484. DOI: 10.1016/j.ijid.2013.12.010. View

16.

Swanson E, Schleiss M . Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am. 2013; 60(2):335-49. PMC: 3807860. DOI: 10.1016/j.pcl.2012.12.008. View

17.

Shim G . Treatment of congenital cytomegalovirus infection. Clin Exp Pediatr. 2023; 66(9):384-394. PMC: 10475861. DOI: 10.3345/cep.2022.01032. View

18.

Boppana S, Ross S, Fowler K . Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013; 57 Suppl 4:S178-81. PMC: 4471438. DOI: 10.1093/cid/cit629. View